RDNZ actively engages with rare disease issues by responding to calls for submissions.

 

Jun 11, 2024, 1:54 PM
Submission by AGenDA on the Contracts of Insurance Bill

The Contracts of Insurance Bill provides a unique opportunity for AGenDA to draw attention to New Zealand’s Insurance Law framework's lack of protection against genomic discrimination, making it the only OECD country without such protection.

Apr 29, 2024, 10:36 PM
Budget Policy Submission

Rare Disorders NZ has made a Budget Policy Submission to the Finance and Expenditure Committee.

Apr 29, 2024, 1:02 PM
Submission on proposal to fund continuous glucose monitors, insulin pumps, and insulin pump consumables

We welcome the inclusion of pancreatogenic diabetes mellitus in the conditions that these products are proposed to be funded for, and appreciate that the definition used includes rare causes of pancreatogenic diabetes like Cystic Fibrosis and Permanent Neonatal Diabetes Mellitus.

Mar 25, 2024, 12:14 PM
Submission to the New Zealand Royal Commission COVID-19 Lessons Learned Te Tira Ārai Urutā public consultation

Rare Disorders NZ commends New Zealand's public health response to the COVID-19 pandemic that meant mortality from Covid-19 in New Zealand has been kept relatively low compared to other similar nations. To perform better in any future pandemic or health crises, it is crucial to acknowledge that individuals within the rare disorder community have encountered significant challenges from the onset of the pandemic until today. These challenges are likely to persist in the future, both concerning COVID-19 and beyond.

Mar 11, 2024, 11:28 AM
Submission on proposal to fund vaccine for the prevention of shingles in immunocompromised people

Rare Disorders NZ supports the principles behind the proposal to widen the access for recombinant varicella zoster virus vaccine (branded as Shingrix) for prevention of shingles in immunocompromised people. However, we are concerned by the very narrow criteria.

Feb 8, 2024, 10:23 PM
Submission to Pharmac on proposal to decline inactive funding applications

Rare Disorders NZ is pleased to see Pharmac aiming to provide more clarity about which medicines they are actively considering for funding.

Dec 4, 2023, 2:10 PM
Submission to Pharmac on Proposal to fund supplements for phenylketonuria

We are pleased to see that people with phenylketonuria (PKU) are now having their unmet needs recognised, and New Zealand is making steps towards meeting internationally recognised standards of care.

Sep 21, 2023, 12:20 PM
RDNZ submission on draft statement on disclosure of harm following an adverse event

Rare Disorders NZ made a submission calling for misdiagnosis and delayed diagnosis to be recognised as causing harm. 

Aug 17, 2023, 12:25 PM
Submission to Pharmac on proposal to change the access criteria for COVID-19 antiviral treatments

Rare Disorders NZ has been advocating for the widening of access to COVID-19 antiviral treatment for some time and has made a submission to Pharmac on the proposal to change the access criteria.

Jul 9, 2023, 11:04 PM
Submission to Pharmac on Proposal to fund Emicizumab for severe Haemophillia A

Rare Disorders NZ supports the proposal to widen access to emicizumab, brand name Hemlibra, for the treatment of severe Haemophilia A without FVIII inhibitors, subject to eligibility criteria.